I-Corps: Barcode embedded rapid diagnostic tests for point-of-care fertility tests

该I-Corps项目的更广泛影响/商业潜力是将临床诊断测定从实验室转移到家庭环境。虽然其他行业最近经历了消费者赋权的激增，但医疗保健作为一个领域，在采用适合这种消费模式的新技术方面一直进展缓慢。这个I-Corps项目旨在评估这样一种技术的市场：移动电话连接的即时诊断测试。在授予期间，该团队将评估消费者偏好，确定客户关注的问题，并评估这些诊断测试的产品市场适合度。拟议项目的成功完成有可能在财政和地理上扩大获得准确的临床检测的机会。这个I-Corps项目旨在评估一种新型家庭诊断检测的商业潜力。这些测试由一部移动的手机进行分析，然后将结果安全地传输到患者的电子医疗记录中。这项技术以前曾被证明用于全球关注的传染病，特别是疟疾和艾滋病毒。在以前的工作中，已经表明，这些手机分析测试可以作为昂贵的实验室仪器测试分析的敏感性。此外，这些测试是用户友好的，在使用前需要最少的说明。重要的是，这使得它们适合一般人群在家中使用。

The broader impact/commercial potential of this I-Corps project is the shift of clinical diagnostic assays from the laboratory to the home setting. While other industries have recently experienced a surge in consumer empowerment, healthcare as a field has been slow to adopt new technologies that fit this pattern of consumerization. This I-Corps project seeks to evaluate the market for one such technology: mobile-phone linked point-of-care diagnostic tests. During the award period, the team will assess consumer preferences, identify customer concerns, and evaluate product-market fit for these diagnostic tests. The successful completion of the proposed project has the potential to expand access, both financially and geographically, to accurate clinical assays.This I-Corps project aims to evaluate the commercial potential of a new type of at-home diagnostic test. These tests are analyzed by a mobile phone, which then securely transmits results to a patient's electronic medical records. This technology has previously been demonstrated for infectious diseases of global concern, specifically: malaria and HIV. In previous work, it has been shown that these mobile-phone analyzed tests can be as sensitive as expensive laboratory instrumentation for test analysis. In addition, these tests are user-friendly and require minimal instruction prior to use. Importantly, this makes them amenable to at-home use by the general population.